Press Releases for DSCO

Press Releases
PicksThatMove.Com Announces Investment Opinion: Hot Stocks That Are on the Move
PicksThatMove.Com Announces Investment Opinion: Small Cap Biopharmaceuticals and Biotechnology 101 From PicksThatMove
Discovery Labs Announces Resignation of CEO Robert J. Capetola, Ph.D.; W. Thomas Amick, Chairman of the Board, Appointed Interim CEO
Discovery Labs Provides Second Quarter 2009 Financial Results and Business Strategy Update
Discovery Labs Schedules Conference Call and Webcast
Discovery Labs Reports On Surfaxin End of Review Meeting With FDA
Discovery Labs Announces Completion of $11.3 Million Registered Direct Offering
Discovery Labs and FDA to Meet On June 2, 2009 to Discuss SURFAXIN Complete Response Letter
Discovery Labs to Raise $11.3 Million in Registered Direct Offering
Discovery Labs' Surfaxin(r) Significantly Improves Lung Surfactant Distribution in Preclinical RDS Model
Discovery Labs' KL4 Surfactant Shows Physiologic and Survival Benefit in a Preclinical Model for Severe Respiratory Condition -- Acute Lung Injury
Discovery Labs Receives Notice of Allowance for Patent to Treat Infants At Risk of Developing Bronchopulmonary Dysplasia
Discovery Labs Reports First Quarter 2009 Financial Results
Discovery Labs Presents Pharmacoeconomic Data Linking Decreased Hospital Costs to Reduction in Reintubation Following Surfaxin Use
Discovery Labs Receives Complete Response From FDA for Surfaxin(r) for Prevention of RDS
Discovery Labs Provides Update Regarding Surfactant Aerosol Generation Technology
Beacon Equity Issues Trade Alerts on Market Movers: ELX, DSCO, JOSB, WBSN, RT, IFX - Apr 9 2009 11:28AM
Beacon Equity Issues Trade Alerts on Market Movers: ELX, DSCO, JOSB, WBSN, RT, IFX - Apr 9 2009 10:35AM
Discovery Labs to Highlight Respiratory Pipeline at the Future Leaders in the Biotech Industry Conference
Discovery Labs Advances KL4 Surfactant Technology Platform With Lyophilized Formulation
Discovery Labs Reports Fourth Quarter 2008 Financial Results
Discovery Labs' Surfaxin(r) Phase 2 BPD Clinical Trial Results Published in Pediatrics
New Analysis of Discovery Labs' Phase 3 RDS Trials Identifies Reintubation as Key Risk Factor for Infant Mortality
Discovery Labs Secures $25 Million Committed Equity Financing Facility
Discovery Labs to Present At the Lazard Healthcare Conference
FDA Establishes Target Action Date of April 17, 2009 for Potential Approval of Discovery Labs' Surfaxin(r)
Discovery Labs Reports Third Quarter 2008 Financial Results
Discovery Labs Reports That It Has Not Yet Received FDA Notification Regarding Complete Response
Discovery Labs KL-4 Surfactant Data Presented At Two Key Medical Meetings
Discovery Labs Submits Complete Response to May 2008 FDA Approvable Letter for Surfaxin(r) for RDS
Discovery Labs Reports Technical Achievements Towards Gaining FDA Approval of Surfaxin
Discovery Labs' Aerosolized KL-4 Surfactant Selected for Evaluation in Phase 2a Cystic Fibrosis Clinical Trial
Discovery Labs Reports Progress in Responding to Surfaxin FDA Approvable Letter
Discovery Labs Reports Second Quarter 2008 Financial Results
Discovery Labs Announces Second Quarter Conference Call and Webcast
Discovery Labs KL-4 Surfactant Anti-Inflammatory Data Published in Pediatric Research
Discovery Labs to Present At the Jefferies Healthcare Conference
Discovery Labs and FDA Meet to Clarify Limited Items in SURFAXIN Approvable Letter
BeaconEquity.com Issues Trader Notes on BCFT, ABPI, AGU, MCHP, DSCO, AMAT, NVDA, SPLS
Discovery Labs and FDA to Meet On June 18, 2008 to Clarify Limited Items in SURFAXIN Approvable Letter
Discovery Labs Secures $60 Million Committed Equity Financing Facility
Securities Class Action Against Discovery Labs is Dismissed
Discovery Labs Presents SURFAXIN Data At Pediatric Academic Societies Annual Meeting
Discovery Labs KL-4 Surfactant Technology Displays Antimicrobial Properties and Does Not Induce Immune Response in Preclinical Models
BeaconEquity.com Issues TraderNotes on EEGC, DSCO, ARTG, SCMR, XDSL - May 27 2008 1:17AM
Emerging Stock Report for Tuesday May 6, 2008: PUBM Experienced Entertainment Executive! - May 27 2008 1:17AM
Discovery Labs Reports First Quarter 2008 Financial Results
Emerging Stock Report for Monday May 5, 2008: LGDI Long Term Agreement With India's Largest Fertilizer Enterprise! - May 27 2008 1:16AM
Discovery Labs Provides Guidance On FDA Approvable Letter for Surfaxin for RDS
Discovery Labs Receives An Approvable Letter From FDA for Surfaxin for RDS
BellwetherReport.com Initiates Analyst Coverage on FEED, ARUN, DSCO and JRCC
Discovery Labs and Chrysalis Technologies Modify Collaboration for Future Development of Aerosolized Drug Device Products